239 related articles for article (PubMed ID: 30318399)
21. Residual effect of community antimicrobial exposure on risk of hospital onset healthcare-associated Clostridioides difficile infection: a case-control study using national linked data.
Pan J; Kavanagh K; Marwick C; Davey P; Wuiff C; Bryson S; Robertson C; Bennie M
J Hosp Infect; 2019 Nov; 103(3):259-267. PubMed ID: 31173780
[TBL] [Abstract][Full Text] [Related]
22. Electronic health record-based detection of risk factors for Clostridium difficile infection relapse.
Hebert C; Du H; Peterson LR; Robicsek A
Infect Control Hosp Epidemiol; 2013 Apr; 34(4):407-14. PubMed ID: 23466915
[TBL] [Abstract][Full Text] [Related]
23. Proton Pump Inhibitors and the Risk for Hospital-Acquired Clostridium difficile Infection.
Barletta JF; El-Ibiary SY; Davis LE; Nguyen B; Raney CR
Mayo Clin Proc; 2013 Oct; 88(10):1085-90. PubMed ID: 24012413
[TBL] [Abstract][Full Text] [Related]
24. Multicentre derivation and validation of a simple predictive index for healthcare-associated Clostridium difficile infection.
Davis ML; Sparrow HG; Ikwuagwu JO; Musick WL; Garey KW; Perez KK
Clin Microbiol Infect; 2018 Nov; 24(11):1190-1194. PubMed ID: 29454848
[TBL] [Abstract][Full Text] [Related]
25. Implementation of Global Strategies to Prevent Hospital-Onset Clostridium difficile Infection: Targeting Proton Pump Inhibitors and Probiotics.
Lewis PO; Lundberg TS; Tharp JL; Runnels CW
Ann Pharmacother; 2017 Oct; 51(10):848-854. PubMed ID: 28821215
[TBL] [Abstract][Full Text] [Related]
26. Microbial Preparations (Probiotics) for the Prevention of Clostridium difficile Infection in Adults and Children: An Individual Patient Data Meta-analysis of 6,851 Participants.
Johnston BC; Lytvyn L; Lo CK; Allen SJ; Wang D; Szajewska H; Miller M; Ehrhardt S; Sampalis J; Duman DG; Pozzoni P; Colli A; Lönnermark E; Selinger CP; Wong S; Plummer S; Hickson M; Pancheva R; Hirsch S; Klarin B; Goldenberg JZ; Wang L; Mbuagbaw L; Foster G; Maw A; Sadeghirad B; Thabane L; Mertz D
Infect Control Hosp Epidemiol; 2018 Jul; 39(7):771-781. PubMed ID: 29695312
[TBL] [Abstract][Full Text] [Related]
27. The evaluation of Clostridium difficile infection (CDI) in a community hospital.
Daniel A; Rapose A
J Infect Public Health; 2015; 8(2):155-60. PubMed ID: 25301221
[TBL] [Abstract][Full Text] [Related]
28. Evaluating the Effectiveness of an Antimicrobial Stewardship Program on Reducing the Incidence Rate of Healthcare-Associated Clostridium difficile Infection: A Non-Randomized, Stepped Wedge, Single-Site, Observational Study.
DiDiodato G; McArthur L
PLoS One; 2016; 11(6):e0157671. PubMed ID: 27309536
[TBL] [Abstract][Full Text] [Related]
29. Investigation to identify a resource-efficient case-control methodology for determining antibiotics associated with Clostridium difficile infection.
Chung P; Currie B; Guo Y; Talansky M; Brown S; Ostrowsky B
Am J Infect Control; 2014 Oct; 42(10 Suppl):S264-8. PubMed ID: 25239720
[TBL] [Abstract][Full Text] [Related]
30. Prospective derivation and validation of a clinical prediction rule for recurrent Clostridium difficile infection.
Hu MY; Katchar K; Kyne L; Maroo S; Tummala S; Dreisbach V; Xu H; Leffler DA; Kelly CP
Gastroenterology; 2009 Apr; 136(4):1206-14. PubMed ID: 19162027
[TBL] [Abstract][Full Text] [Related]
31. A Generalizable, Data-Driven Approach to Predict Daily Risk of Clostridium difficile Infection at Two Large Academic Health Centers.
Oh J; Makar M; Fusco C; McCaffrey R; Rao K; Ryan EE; Washer L; West LR; Young VB; Guttag J; Hooper DC; Shenoy ES; Wiens J
Infect Control Hosp Epidemiol; 2018 Apr; 39(4):425-433. PubMed ID: 29576042
[TBL] [Abstract][Full Text] [Related]
32. Community-onset Clostridium difficile infection at a tertiary medical center in southern Taiwan, 2007-2015.
Tsai CS; Hung YP; Lee JC; Lee NY; Chen PL; Syue LS; Li MC; Li CW; Ko WC
J Microbiol Immunol Infect; 2018 Apr; 51(2):243-250. PubMed ID: 28089100
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of a risk score to predict future
Marley C; El Hahi Y; Ferreira G; Woods L; Ramirez Villaescusa A
Hum Vaccin Immunother; 2019; 15(10):2475-2481. PubMed ID: 30945972
[TBL] [Abstract][Full Text] [Related]
34. Predictors of hospital-onset Clostridioides difficile infection in children with antibiotic-associated diarrhea.
Polat M; Tapısız A; Demirdağ TB; Yayla BC; Kara SS; Tezer H; Belet N; Çırak MY
Am J Infect Control; 2023 Aug; 51(8):879-883. PubMed ID: 36535316
[TBL] [Abstract][Full Text] [Related]
35. Clostridium difficile in an Urban, University-Affiliated Long-Term Acute-Care Hospital.
Jacob J; Wu J; Han J; Nelson DB
Infect Control Hosp Epidemiol; 2017 Mar; 38(3):294-299. PubMed ID: 27923419
[TBL] [Abstract][Full Text] [Related]
36. Identification of population at risk for future Clostridium difficile infection following hospital discharge to be targeted for vaccine trials.
Baggs J; Yousey-Hindes K; Ashley ED; Meek J; Dumyati G; Cohen J; Wise ME; McDonald LC; Lessa FC
Vaccine; 2015 Nov; 33(46):6241-9. PubMed ID: 26450660
[TBL] [Abstract][Full Text] [Related]
37. Factors associated with Clostridium difficile infection: A nested case-control study in a three year prospective cohort.
Khanafer N; Vanhems P; Barbut F; Luxemburger C; ; Demont C; Hulin M; Dauwalder O; Vandenesch F; ; Argaud L; Badet L; Barth X; Bertrand M; Burillon C; Chapurlat R; Chuzeville M; Comte B; Disant F; Fessy MH; Gouillat C; Juillard L; Lermusiaux P; Monneuse O; Morelon E; Ninet J; Ponchon T; Poulet E; Rimmele T; Tazarourte K
Anaerobe; 2017 Apr; 44():117-123. PubMed ID: 28279859
[TBL] [Abstract][Full Text] [Related]
38. Clostridium difficile Infection in Trauma, Surgery, and Medical Patients Admitted to the Intensive Care Unit.
Watkins RR; Mangira C; Muakkassa F; Donskey CJ; Haller NA
Surg Infect (Larchmt); 2018 Jul; 19(5):488-493. PubMed ID: 29708848
[TBL] [Abstract][Full Text] [Related]
39. The Effect of Saccharomyces boulardii Primary Prevention on Risk of Hospital-onset Clostridioides difficile Infection in Hospitalized Patients Administered Antibiotics Frequently Associated With C. difficile Infection.
Wombwell E; Patterson ME; Bransteitter B; Gillen LR
Clin Infect Dis; 2021 Nov; 73(9):e2512-e2518. PubMed ID: 32575126
[TBL] [Abstract][Full Text] [Related]
40. Medication risk factors associated with healthcare-associated Clostridium difficile infection: a multilevel model case-control study among 64 US academic medical centres.
Pakyz AL; Jawahar R; Wang Q; Harpe SE
J Antimicrob Chemother; 2014 Apr; 69(4):1127-31. PubMed ID: 24327619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
